Title Povezanost polimorfizama gena za metilentetrahidrofol at reduktazu i multiple skleroze
Title (english) Association between methylenetetrahydr ofolate reductase gene polymorphisms and multiple sclerosis
Author Monika Pavlović
Mentor Nada Starčević-Čizmarević (mentor)
Committee member Nada Starčević-Čizmarević (predsjednik povjerenstva)
Committee member Anđelka Radojčić Badovinac (član povjerenstva)
Committee member Antonija Jurak Begonja (član povjerenstva)
Granter University of Rijeka (Faculty of Biotechnology and Drug Development) Rijeka
Defense date and country 2024-09-24, Croatia
Scientific / art field, discipline and subdiscipline BIOTECHNICAL SCIENCES Biotechnology
Abstract Multipla skleroza (MS) kronična je autoimuna bolest s
neurodegenerativnim posljedicama, koju karakteriziraju upalna područja,
demijelinizacija i degeneracija aksona. Etiologija ove bolesti još uvijek nije
u potpunosti razjašnjena zbog kompleksne veze između okolišnih
čimbenika, genetske predispozicije i virusne infekcije pri čemu ovi faktori
u većoj ili manjoj mjeri mogu igrati ulogu u riziku za razvoj bolesti te nisu
međusobno isključivi. Jedan od gena asociran s podložnošću za MS je
MTHFR gen. Polimorfne varijante gena, MTHFR C677T i MTHFR A1298C,
rezultiraju reduciranom aktivnošću enzima kodiranog pripadnim genom.
Time je narušen balans metabolizma folata i metionina, što uzrokuje
povećane razine neurotoksičnog homocisteina i slobodnih radikala, koji
oštećuju mijelin te smanjene razine S-adenozilmetiona neophodnog za
remijelinizaciju. Dosadašnja istraživanja u različitih populacija pokazala su
nedosljednosti u rezultatima u pokušaju da povežu polimorfizme s
predispozicijom za MS. Ovo istraživanje provedeno je PCR-RFLP metodom
na 200 MS bolesnika i 200 kontrolnih ispitanika u svrhu definiranja uloge
MTHFR polimorfizama u predispoziciji za MS i kliničkoj ekspresiji bolesti.
Obradom rezultata otkriveno je da polimorfizmi MTHFR C677T i MTHFR
A1298C ne pridonose povećanom riziku za MS. Međutim, pronađena je
povezanost između prisustva T alela MTHFR C677T polimorfizma i
povećanog progresijskog indeksa bolesti te potencijalan utjecaj C alela
MTHFR A1298C polimorfizma na trajanje bolesti. Analiza međudjelovanja
između polimorfizama ukazuje na povećan rizik od obolijevanja za osobe s
kombinacijom genotipova CC/AC i moguć smanjen rizik za one s CC/CC
kombinacijom. Zaključno, ispitivani polimorfizmi ne pridonose podložnosti
za MS, ali mogu modificirati eskpresiju bolesti što se mora uzeti s
rezervom obzirom na ograničen broj ispitanika s pojedinim kombinacijama
polimorfizama.
Abstract (english) Multiple sclerosis (MS) is a chronic autoimmune disease with
neurodegenerative consequences, characterized by inflammatory areas,
demyelination and axonal degeneration. The etiology of this disease is still
not fully elucidated due to the complex relationship between
environmental factors, genetic predisposition and viral infection, whereby
these factors can play a role in the risk for the development of the disease
to a greater or lesser extent and are not mutually exclusive. One of the
genes associated with susceptibility to MS is the MTHFR gene. Polymorphic
gene variants, MTHFR C677T and MTHFR A1298C, result in reduced
activity of the enzyme encoded by the corresponding gene. This disrupts
the balance of folate and methionine metabolism, which causes increased
levels of neurotoxic homocysteine and free radicals, which damage myelin,
and reduced levels of S-adenosylmethione, necessary for remyelination.
Previous studies in different populations have shown inconsistencies in the
results in an attempt to link polymorphisms with a predisposition to MS.
This research was conducted using the PCR-RFLP method on 200 MS
patients and 200 control subjects in order to define the role of MTHFR
polymorphisms in the predisposition to MS and the clinical expression of
the disease. Processing the results revealed that the MTHFR C677T and
MTHFR A1298C polymorphisms do not contribute to an increased risk for
MS. However, an association was found between the presence of the T
allele of the MTHFR C677T polymorphism and an increased disease
progression index, and the potential influence of the C allele of the MTHFR
A1298C polymorphism on the duration of the disease. Analysis of the
interaction between polymorphisms indicates an increased risk of the
disease for people with the combination of CC/AC genotypes and a
possible reduced risk for those with the CC/CC combination. In conclusion,
the studied polymorphisms do not contribute to susceptibility to MS, but
they can modify the expression of the disease, which must be taken with
caution considering the limited number of subjects with certain
combinations of polymorphisms.
Keywords
MTHFR - metilentetrahidrofolat reduktaza
multipla skleroza
polimorfizam
genski
Keywords (english)
MTHFR - methylenetetrahydrofolate reductase
multiple sclerosis
polymorphism
genetic
Language croatian
URN:NBN urn:nbn:hr:193:553592
Study programme Title: Biotechnology in medicine Study programme type: university Study level: graduate Academic / professional title: magistar/magistra biotehnologije u medicini (magistar/magistra biotehnologije u medicini)
Type of resource Text
File origin Born digital
Access conditions Open access
Terms of use
Created on 2024-11-04 11:55:55